Navigation Links
Life Sciences Venture Funding Jumps 21% in 2011 but Quarterly Performance Falls Short, According to the MoneyTree Report
Date:2/2/2012

during the fourth quarter of 2011 and Life Sciences companies claimed three of the 11 venture-backed IPOs.  However, at this point in time, M&A deals continue to offer more exit opportunities for Life Sciences companies than IPOs."

The life sciences sector's investment split tilted in Q4 2011. During the fourth quarter, Biotechnology accounted for 72 percent of funding, while medical devices claimed only 28 percent, due to a $265 million drop in dollars invested in the sector. In comparison, during the third quarter of 2011, Biotechnology captured 60 percent of investment in the sector and Medical Devices accounted for 40 percent.

In 2011, Biotechnology investing grew by 22 percent in dollars but declined 9 percent in deals, with $4.7 billion going into 446 deals, second only to the Software industry.  On a year-over-year basis, biotechnology investments increased 46 percent, and the number of deals was flat, with $1.3 billion going into 111 deals during the last quarter of 2011.

Medical device investments rose 20 percent in dollars from 2010 to 2011 and finished relatively flat in terms of deals. With $2.8 billion going into 339 deals, the Medical Device industry ranked behind Software, Biotechnology, and Industrial/Energy in dollars invested.

First-Time Financing

During the fourth quarter of 2011, 34 Life Sciences companies received venture capital funding for the first time, capturing $280 million.  This represents a decrease of 24 percent in the number of companies but a 41 percent increase in dollars invested compared to the fourth quarter of 2010.  First-time deals in the Life Sciences sector jumped to an average of $8.2 million in the fourth quarter of 2011 compared with an average deal size of $4.4
'/>"/>

SOURCE PwC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ronnie Andrews Joins Life Technologies as President, Medical Sciences
2. Vision-Sciences, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 2nd
3. Nautilus Neurosciences Announces New Patent Issued
4. Sapio Sciences Announces Exemplar Dx LIMS for Laboratories in the Burgeoning MDx Market
5. Verify Brand™ Announces the Release of VB Enterprise 4.0 for Life Sciences
6. Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
7. Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock
8. Intellect Neurosciences, Inc. to Present at BIO Asia International Conference
9. Brabender® Pharma USA, Inc. and Particle Sciences Cooperate to Expand Extrusion Capabilities
10. Ambit Biosciences to Present at 30th Annual J.P. Morgan Healthcare Conference
11. Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 Biomedical Catalyst ... Target Prostate Cancer  Crescendo Biologics Limited ... drug conjugate (ADC) programme with the support of ... agency, Innovate UK. This feasibility award will enable ... (HDCs) a novel product format based on Crescendo,s ...
(Date:5/26/2015)... 26, 2015  AbbVie (NYSE: ABBV ) ... study of its investigational, all-oral, interferon (IFN)- and ... at the Annual Meeting of the Japan Society ... . 1 GIFT-I evaluated genotype 1b (GT1b) ... with and without cirrhosis, who were either treatment-naïve ...
(Date:5/26/2015)... May 26, 2015 Depomed, Inc. (NASDAQ: DEPO ... healthcare conferences in June. The 2015 Jefferies ... Jefferies conference is scheduled for 3:00 pm EDT (12:00 noon ... JMP Securities Life Sciences Conference in New York City.  The ... EDT (8:30 am PDT) Wednesday, June 24, 2015. ...
Breaking Medicine Technology:Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6Depomed To Present At Healthcare Conferences In June 2
... 2011 The board of directors of Eli Lilly and Company (NYSE: ... of 2011 of $0.49 a share on outstanding common stock. This is ... 2011 and brings the total annual dividend for 2011 to $1.96 per ... of record at the close of business on November 15, 2011. ...
... SPRING, Md., Oct. 17, 2011 The U.S. Food ... draft special controls guidance lowering the risk classification for ... Class II (moderate-risk). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... to regulate a patient,s heartbeat until a permanent pacemaker ...
Cached Medicine Technology:FDA Proposes Lower Risk Classification, Special Controls for External Pacemakers 2FDA Proposes Lower Risk Classification, Special Controls for External Pacemakers 3
(Date:5/26/2015)... 2015 In celebration of Parker and Sons ... a discount on HVAC systems with a high Season Energy ... HVAC systems with a SEER rating around 15-16 can be ... For those unfamiliar with a SEER rating, it is essentially ... it measures the amount of energy expended by the actual ...
(Date:5/26/2015)... Degeneration of the white matter of ... types of Alzheimer’s disease (AD), including early-onset AD, according ... journal Radiology. , “Alzheimer’s is a gray matter ... study conducted at the Neuroimaging Research Unit, San Raffaele ... has a central role in how the disease strikes ...
(Date:5/26/2015)... (PRWEB) May 27, 2015 The world ... Dr. Delgado ’s quest to remain on the cutting ... to spotlight the many new additions to plastic surgery ... and cosmetic surgical procedures, with emphasis on facelifts and ... design is very user friendly and easy to navigate. ...
(Date:5/26/2015)... 2015 Mr. Gould and Mr. Ken Cochran, ... working together this week to ensure a smooth transition. ... executive leadership and strategy. Gary is familiar with East ... of Mr. Cochran. The Board of Trustees believe Mr. Gould’s ... strategies implemented over the past few years. , “Our ...
(Date:5/26/2015)... Over 700 doctors, nutritionists, nurses, and public health ... of the U.S. Department of Agriculture and the U.S. ... embrace the 2015 Dietary Guidelines Advisory Committee’s recommendations to ... economic prosperity, and our nation’s food security. , Leaders ... Dr. David Katz, founding director of the Yale University ...
Breaking Medicine News(10 mins):Health News:Parker and Sons Recounts its Path to Success 2Health News:RSNA: Imaging Test May Identify Biomarker of Alzheimer’s Disease 2Health News:RSNA: Imaging Test May Identify Biomarker of Alzheimer’s Disease 3Health News:Miguel Delgado, M.D. Launches Two New Plastic Surgery Websites 2Health News:Miguel Delgado, M.D. Launches Two New Plastic Surgery Websites 3Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 3
... it is working on four vaccines, including those for ... are currently working on four vaccines for anthrax, dengue, ... for anthrax vaccine have been completed, which is ready ... Jain told reporters here today., ,The company would ...
... lesions, that typically precede cervical cancer is much higher ... papillomavirus (HPV) than previously reported, according to a study ... & Prevention. ,Although doctors have known that ... can harbor multiple HPV types, this study is the ...
... at New South Wales central coast are in the process ... financial// support from the vaccine company in the US. ... immunise animals against the infection. ,As chlamydial infection ... for the past seven years to find a cure against ...
... with Publix Super Markets of Lakeland, Florida, are issuing ... Chip Cookie Dough. ,According to Maria Brous, ... "The chocolate chip dough may contain pecans. As a ... have been no reported cases of illness. Customers who ...
... study of women in the Nurses' Health Study has shown ... glaucoma (POAG), the most common form of glaucoma//, accounting for ... published in the July issue of the journal Ophthalmology. ... and Women's ,Hospital, Harvard School of Public Health and Harvard ...
... drugs used to reduce the levels of LDL cholesterol ... can cause serious muscle// damage. ,Health Canada ... Lipitor, Pravachol, Zocor, Crestor and Mevacor to include warnings ... patient safety information sheets. ,Statin drug users ...
Cached Medicine News:Health News:Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types 2Health News:Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types 3Health News:Type 2 Diabetes Increases the Risk of Glaucoma in Women 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: